Clin Infect Dis. 2003 Apr 1;36(Suppl 2):S79-83.

Lipid abnormalities.

Source

Indiana University School of Medicine, Wishard Memorial Hospital, Division of Infectious Diseases, Indianapolis, Indiana 46202-2879 , USA. mpdube@iupui.edu

Abstract

Dyslipidemia is an important clinical problem in individuals infected with human immunodeficiency virus (HIV) who are receiving antiretroviral therapy. Data suggest that increased cardiovascular disease is occurring in this population. HIV-infected individuals should undergo evaluation and treatment regimens based on the current National Cholesterol Education Program guidelines. In most situations, the first interventions should be nonpharmacological and should include diet, exercise, and management of other hygienic risk factors. If pharmacologic therapy becomes necessary, the choices of lipid-lowering agents should be limited to agents with the least likelihood of adverse drug interactions.

PMID:: 12652375; [PubMed - indexed for MEDLINE]

Free full text

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Review Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management. [Int J Antimicrob Agents. 2003]
Review Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.
Calza L, Manfredi R, Chiodo F. Int J Antimicrob Agents. 2003 Aug; 22(2):89-99.
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. [Clin Infect Dis. 2000]
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
Dubé MP, Sprecher D, Henry WK, Aberg JA, Torriani FJ, Hodis HN, Schouten J, Levin J, Myers G, Zackin R, et al. Clin Infect Dis. 2000 Nov; 31(5):1216-24. Epub 2000 Nov 7.
Review Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients. [Curr Pharm Des. 2003]
Review Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
Barbaro G, Klatt EC. Curr Pharm Des. 2003; 9(18):1475-81.
Review Cardiovascular risk among HIV-positive patients on antiretroviral therapy. [J Int Assoc Physicians AIDS Care (Chic). 20...]
Review Cardiovascular risk among HIV-positive patients on antiretroviral therapy.
Aberg JA. J Int Assoc Physicians AIDS Care (Chic). 2003 Sep; 2 Suppl 2:S24-39.
Review Dyslipidaemia and cardiovascular risk in HIV infection. [Curr Med Res Opin. 2005]
Review Dyslipidaemia and cardiovascular risk in HIV infection.
Kulasekaram R, Peters BS, Wierzbicki AS. Curr Med Res Opin. 2005 Nov; 21(11):1717-25.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Lipid abnormalities.
Lipid abnormalities.
Clin Infect Dis. 2003 Apr 1 ;36(Suppl 2):S79-83.

PubMed
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with re...
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
J Neurooncol. 2005 Feb ;71(3):301-5.

PubMed
Primary paraganglioma strictly confined to the liver and mimicking hepatocellula...
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: an immunohistochemical and in situ hybridization study.
Am J Surg Pathol. 2002 Jul ;26(7):945-9.

PubMed
The clinical aspects, diagnosis and therapy of primary liver cancer.
The clinical aspects, diagnosis and therapy of primary liver cancer.
Acta Unio Int Contra Cancrum. 1957 ;13(4-5):669-81; discussion 681-3.

PubMed
Regulation of virulence gene expression in Vibrio cholerae by quorum sensing: Ha...
Regulation of virulence gene expression in Vibrio cholerae by quorum sensing: HapR functions at the aphA promoter.
Mol Microbiol. 2002 Nov ;46(4):1135-47.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Lipid abnormalities.

Source

Abstract

MeSH Terms

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information